Moreover, in NSCLC, apatinib has been observed to induce the generation of ROS, suppress the expression of Nrf2 and p62, trigger autophagy and apoptosis, and inhibit tumor proliferation, both in vitro and in vivo141. The gene discussed is NFE2L2; the disease is neoplasm.